Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.64 |
| ▸ | SLC6A1 | P30531 | 7/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11197152 | 0.93 | SLC6A1 (0.70) | SIGMAR1SLC6A1ALDH1A1LMNACYP1A2 | |
| Hydrochloric Acid SCHEMBL10941244 | 0.91 | SIGMAR1 (0.64) | SIGMAR1SLC6A1ALDH1A1LMNACYP1A2 | |
| Maleic Acid SCHEMBL10966258 | 0.88 | SLC6A1 (0.65) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 | |
| Fumaric Acid SCHEMBL10966268 | 0.88 | SLC6A1 (0.65) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL11033443 | 0.88 | ALDH1A1 (0.51) | SIGMAR1SLC6A1ALDH1A1LMNACYP1A2 | |
| Hydrochloric Acid SCHEMBL10945909 | 0.88 | ALDH1A1 (0.51) | SIGMAR1SLC6A1ALDH1A1LMNACYP1A2 | |
| SCHEMBL10938841 | 0.88 | SLC6A1 (0.50) | SIGMAR1SLC6A1ALDH1A1LMNACYP1A2 | |
| SCHEMBL10938825 | 0.88 | SLC6A1 (0.50) | SIGMAR1SLC6A1ALDH1A1LMNACYP1A2 | |
| SCHEMBL10938814 | 0.88 | SLC6A1 (0.50) | SIGMAR1SLC6A1ALDH1A1LMNACYP1A2 | |
| SCHEMBL10938940 | 0.87 | SIGMAR1 (0.60) | SIGMAR1SLC6A1ALDH1A1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1142584-A1 | COMPOSITIONS FOR TREATING FREQUENT URINATION AND URINARY INCONTINENCE | Takeda Chemical Industries, Ltd. (JP) | 2001-10-10 | — | — | EP | claimed |
| US-4514414-A | NEUROLEPTIC AGENTS | SMITHKLINE BECKMAN CORPORATION (US) | 1985-04-30 | — | — | US | claimed |
| EP-0912091-B1 | USE OF GABA UPTAKE INHIBITORS AS ANTI-TUSSIVE AGENTS | SMITHKLINE BEECHAM CORP (US) | 2007-12-19 | — | — | EP | disclosed |
| EP-1142584-A1 | COMPOSITIONS FOR TREATING FREQUENT URINATION AND URINARY INCONTINENCE | Takeda Chemical Industries, Ltd. (JP) | 2001-10-10 | — | — | EP | disclosed |
| JP-2000264848-A | COMPOSITION FOR TREATING POLLAKIURIA AND ACONUROSIS | TAKEDA CHEM IND LTD | 2000-09-26 | — | — | JP | disclosed |
| US-6121290-A | TREATING COUGH BY ADMINISTERING A COMPOUND THAT INHIBITS GABA (GAMMA-AMINO-BUTYRIC ACID) UPTAKE, SUCH AS GUVACINE | SMITHKLINE BEECHAM CORPORATION (US) | 2000-09-19 | — | — | US | disclosed |
| US-4514414-A | NEUROLEPTIC AGENTS | SMITHKLINE BECKMAN CORPORATION (US) | 1985-04-30 | — | — | US | disclosed |